Lonza Capacity Update July 2025: Small Molecule Drug Substance/API

Lonza is a preferred global partner to the pharmaceutical, biotech and nutrition markets. We work to enable a healthier world by supporting our customers to deliver new and innovative medicines that help treat a wide range of diseases. We achieve this by combining technological insight with world-class manufacturing, scientific expertise and process excellence. Our unparalleled breadth of offerings enables our customers to commercialize their discoveries and innovations in the healthcare industry.

ASDs continue to be an attractive option for progressing and commercializing poorly soluble compounds. This talk will focus on capabilities to screen the potential for ASDs in early phase studies as well as their commercial applicability.